1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Wuxi NextCODE Genomics

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2011

Location

Shanghai China

Primary Industry

Biotechnology

About

Established in 2011 and headquartered in Shanghai, China, Wuxi NextCODE Genomics (formerly known as WuXi Genome Center) is a clinical diagnostics company that provides sequencing solutions for personalized medicine. In 2015, the entity was merged with NextCODE Health.
Current Investors
Temasek Holdings, Ping An Insurance Group, Boyu Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment, Medical Software
Website
www.wuxinextcode.cn
Verticals
Big Data
Company Stage
Series C
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo